CClinicalTrials.gg
CompletedNCT02945072PSTUpdated Dec 19, 2024

Clinical Study of Behavior Problems in Children After Different Anesthesia Methods

A Phase 4 interventional study of TIVA and Sevoflurane in Child Behavior and Problem Behavior, sponsored by University Children's Hospital, Zurich. Completed at 1 site in Switzerland. Open to participants aged 2 Years to 10 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-19.

Sponsored by University Children's Hospital, Zurich · Phase 4, Interventional, and Screening

Phase
Phase 4
Study type
Interventional
Enrollment
500
Allocation
Randomized
Ages
2 Years to 10 Years
Sex
All
01

Study summary

The aim of this study is to investigate long-lasting or later behavioral changes in children in the context of different anesthesia techniques (Inhalation anesthesia vs. TIVA)

Read the detailed description

The process of surgery and anaesthesia can be an extremely frightening and stressful event for a child, and is frequently followed by negative postoperative behavioural changes. This Event could be associated with poor postoperative outcome and long term behavior problems like anxiety, eating or sleeping disorders. The aim of this study is to investigate long-lasting or later behavioral changes in children in the context of different anesthesia techniques (Inhalation anesthesia vs. TIVA). After anesthesia initiation, anesthesia maintenance should be done with sevoflurane or Tiva. The effect of behavioral changes in children in the context of anesthesia techniques should be evaluate by post hospitalisation behavior and Strengths and Difficulties Questionnaire at first, second and fourth week. Early postoperative problems like postoperative nausea and vomiting, pain level, pain therapy and postoperative awareness should be evaluate too.

02

Conditions studied

  • Child Behavior
  • Problem Behavior

Browse trials for

Keywords

  • Child Behavior
  • Problem Behavior
  • postoperative behaviour problems
03

In context

Problem Behavior

517 studies on the registry are indexed under Problem Behavior; 92 are open to participants now.

This study's enrollment of 500 is above the median of 90 across 391 interventional studies indexed under Problem Behavior.

Browse Problem Behavior studies →

Lead sponsor

University Children's Hospital, Zurich is the lead sponsor of 92 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • elective Operation
  • operation in general anesthesia in combination with regional anesthesia
  • Age 2-10 years
  • ASA classification 1 or 2 (without severe basic disease or disability)

Exclusion criteria

Exclusion Criteria:

  • Lack of Consensus
  • general anesthesia during the last 3 months before or 4 weeks after the procedure
  • PONV prophylaxis with droperidol
  • severe known growth factor
  • mental pre-existing conditions and behavioral abnormalities
  • contraindications for one of the used study medications
  • insufficient regional anesthesia
  • secondary intervention within of the 4-week follow-up
05

Study design

Phase
Phase 4
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
500 participants (actual)

Study arms

  • Active comparator
    Sevoflurane group

    general anesthesia will be maintained with sevoflurane

    Procedure: Sevoflurane

  • Experimental
    TIVA group

    general anesthesia will be maintained with total intravenous anesthesia (propofol and remifentanyl)

    Procedure: TIVA

Interventions

  • ProcedureTIVA

    TIVA is use to anesthesia maintenance after anesthesia induction (Propofol 10mg/kg/h, Remifentanil 0.2mcg/kg/min, dose adaptation as required for sufficient anesthesia)

  • ProcedureSevoflurane

    Sevoflurane is use to anesthesia maintenance after anesthesia induction (target et 2 Vol% in 50-70% N2O, dose adaptation as required)

06

What researchers measure

Primary outcomes

  1. Post-Hospital Behaviour Questionnaire (PHBQ) score postoperatively

    child's PHBQ score first week postoperatively

    Time frame: first week postoperative

  2. Post-Hospital Behaviour Questionnaire (PHBQ) score postoperatively

    child's PHBQ score second week postoperatively

    Time frame: second week postoperative

  3. Post-Hospital Behaviour Questionnaire (PHBQ) score postoperatively

    child's PHBQ score fourth week postoperatively

    Time frame: fourth week postoperative

  4. SDQ Questionnaire score postoperatively

    child's SDQ score first week postoperatively

    Time frame: first week postoperative

  5. SDQ Questionnaire score postoperatively

    child's SDQ score second week postoperatively

    Time frame: second week postoperative

  6. SDQ Questionnaire score postoperatively

    child's SDQ score fourth week postoperatively

    Time frame: fourth week postoperative

Secondary outcomes

  1. postoperative pain Level (by VAS)

    Visual Analog Scale for Pain (VAS Pain) were used to evaluate postoperative pain level

    Time frame: in the first postoperative week (3 times a day)

  2. postoperative pain Level (by CHEOPS)

    CHEOPS (Children's Hospital of Eastern Ontario Pain Scale) were used to evaluate postoperative pain level

    Time frame: in the first postoperative week (3 times a day)

  3. postoperative pain medication

    All pain medications are recorded during the first postoperative week.Nurses and parents recorded all substance and application times by questionnaire.

    Time frame: in the first postoperative week

  4. Intraoperative awareness

    In order to record an intraoperative awareness, a semistructured interview is conducted with test questions.

    Time frame: in the first and second postoperative day

  5. postoperative Nausea and vomiting

    Nausea and Vomiting are recognized in frequency and time using a questionnaire.

    Time frame: in the first and second postoperative day

07

Study locations

1 site
  • Dr. Philipp Buehler
    Zurich, 8032, Switzerland
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02945072
Lead sponsor
University Children's Hospital, Zurich
Responsible party
Sponsor
First posted
Oct 26, 2016
Start date
Jan 22, 2018
Primary completion
Jun 4, 2024
Completion
Jun 4, 2024
Last update
Dec 19, 2024

Study contacts

Philipp Buehler, MD
study chair · University children hosptial Zurich

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion